What are the Challenges in Targeting Exhausted T Cells?
Despite the success of checkpoint inhibitors, challenges remain in targeting exhausted T cells. Not all patients respond to these therapies, and resistance can develop. The complexity of the tumor microenvironment and the presence of multiple inhibitory pathways contribute to these challenges. Research is ongoing to identify new targets and combination strategies to overcome these hurdles.
